Reusing a syringe, even on the same vial, is a major source of contamination
As a modified C-terminal fragment of human growth hormone (hGH fragment 177-191), this peptide is highly sought after in metabolic and lipolytic research models
In this way, GH and insulin act in symphony with IGF-1 to produce a coordinated response
Let your provider know if anything unusual happens
availability has been significantly curtailed - No branded pharmaceutical product exists **Semaglutide:** - FDA-approved for weight management (Wegovy, 2.4 mg weekly) - FDA-approved for type 2 diabetes (Ozempic, up to 2.0 mg weekly) - Available through licensed pharmacies worldwide - Also available through 503B compounding pharmacies as a **weight loss peptide injection** - [View semaglutide products](/products/semaglutide-001) ### Injection Protocol Comparison **AOD-9604 typical research protocol:** - Dose: 250-300 mcg per injection - Frequency: Daily subcutaneous injection (fasting, typically morning) - Cycle length: 12-20 weeks - Total injections per month: ~30 **Semaglutide weight loss injection protocol:** - Starting dose: 0.25 mg weekly (4-week titration steps) - Maintenance dose: 2.4 mg weekly - Frequency: Once weekly subcutaneous injection - Total injections per month: 4 The convenience advantage is substantial
Neither insulin nor IGF-1 caused any significant change in mitochondrial mass compared to untreated cells (Fig
